Peregrin Activators
Chemical activators of Peregrin can exert their influence through the modulation of chromatin dynamics, leading to its functional activation. Bromodomain inhibitors such as JQ1, I-BET151, PFI-3, CPI-0610, OTX015, RVX-208, and GSK525762A can enhance the ability of Peregrin to interact with chromatin. These inhibitors target the BET family of bromodomains, which are known to compete with Peregrin for binding sites on acetylated histones. By inhibiting BET proteins, these chemical activators reduce competitive inhibition, effectively increasing the availability of acetylated lysine residues on histones for Peregrin to bind. This is crucial for Peregrin's role in chromatin remodeling and gene expression regulation. As Peregrin binds to these acetylation marks, it can exert its function in modulating the chromatin structure, thereby influencing the transcription of genes necessary for various cellular processes.
Further, histone deacetylase (HDAC) inhibitors such as MS-275, Vorinostat, Panobinostat, and Belinostat can lead to an increase in the acetylation levels on histones. This hyperacetylation creates a more open chromatin conformation, which not only is more conducive to transcriptional activation but also provides more binding opportunities for Peregrin. By increasing the acetylation mark density on histones, these HDAC inhibitors can indirectly facilitate the functional activation of Peregrin. On the other hand, C646, a histone acetyltransferase inhibitor, can affect the balance of acetylation on histones, creating a more favorable environment for Peregrin to bind and exert its regulatory functions on the chromatin structure. Through these various mechanisms, each chemical activator contributes to the functional activation of Peregrin by enhancing its association with chromatin, thus influencing the transcriptional landscape within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 targets the BET family of bromodomain proteins, potentially increasing the accessibility of chromatin for transcription factors and co-activators, including Peregrin, thereby functionally activating Peregrin's role in chromatin remodeling. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor that could displace competition at acetylated histone binding sites, potentially enhancing the binding affinity of Peregrin to chromatin, leading to its functional activation in gene expression regulation. | ||||||
PFI 3 | 1819363-80-8 | sc-507340 | 10 mg | $300.00 | ||
PFI-3 specifically inhibits the SMARCA bromodomains, which may indirectly activate Peregrin by allowing it to bind to the newly available acetylated histone sites, leading to functional activation of Peregrin's chromatin modification activity. | ||||||
CPI-0610 | 1380087-89-7 | sc-507490 | 10 mg | $495.00 | ||
CPI-0610 acts as a BET bromodomain inhibitor, which can indirectly facilitate Peregrin's binding to chromatin by reducing competitive inhibition, thereby functionally activating Peregrin in mediating chromatin dynamics and gene expression. | ||||||
(S)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide | 202590-98-5 | sc-501130 | 2.5 mg | $330.00 | ||
Also called OTX015, this compound is another BET bromodomain inhibitor that might enhance Peregrin's chromatin association and hence its activity in epigenetic regulation by reducing the competitive bromodomain interactions at acetylated lysines on histones. | ||||||
RVX 208 | 1044870-39-4 | sc-472700 | 10 mg | $340.00 | ||
RVX-208, a BET inhibitor, might indirectly activate Peregrin by altering the chromatin landscape, potentially increasing Peregrin's access to chromatin substrates and functionally activating its role in transcriptional regulation. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
As a BET inhibitor, GSK525762A could indirectly activate Peregrin by modulating chromatin structure, thus promoting Peregrin's engagement with chromatin and functional activation in epigenetic modulation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275, a histone deacetylase inhibitor, may increase acetylation levels on histones, enhancing the potential for Peregrin to bind to acetylated histones and functionally activate its chromatin remodeling capabilities. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, also known as Suberoylanilide Hydroxamic Acid, is a histone deacetylase inhibitor that could increase the acetylation of histones, indirectly facilitating Peregrin's functional activation by increasing its access to epigenetic marks on chromatin. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent histone deacetylase inhibitor which may enhance Peregrin's chromatin association and activity by increasing the acetylation levels of histones, a substrate for Peregrin's bromodomain. | ||||||